Atlanta woman launches 'Souper Kindness' tour, feeding strangers across America
Facebook

When my friend Jenny Levison told me she was launching what she called a "Kindness Tour," in the middle of the pandemic last year, I thought she'd lost her mind.

Levison is a celebrity chef and the owner of five "Souper Jenny" restaurants in the Atlanta area. To say that she walks to the beat of her own drum is an understatement. Once she makes her mind up to do something, there really isn't any stopping her. And she is someone who is committed both in her life and her work to giving back, paying it forward, and helping those who need it -- even if that means renting an RV, covering it with peace stickers, and heading out on the road to give away free food for weeks at a time.

Levison tells me that the first "Souper Jenny Kindness Tour" was born out of a drive to help people having a rough time in 2020. Knowing how hard the restaurant industry was hit and all the people who were impacted by it, she launched a six-week tour from Atlanta to California last October.

"Everyone was struggling and frankly, I needed some hope as well. I called one of my besties and told her what I wanted to do. I wanted to hop in an RV, drive west and start to spread the word that hope and joy were still alive and kindness was the new cool."

She says the first trip was "life-changing."



"We walked the bridge in Selma, which I've never done before and I could feel the weight of our history. We brought a wagon filled with quarts of soup and we handed them out on the bridge. Someone told us about some low-income housing in the area. So, we headed over. This white Jewish girl showed up in their neighborhood and I was welcomed with open arms by the community," Levison says.

She and her friend, and co-captain on their wild adventure, Meg Gillentine Morris, stopped at local farms and bought out their produce. They'd use the produce to make soup and find ways to feed communities in need. They'd set up socially distant takeout tables and give away free soup in the RV parks where they stopped. They'd leave quarters for people to do their laundry in laundromats. They did a free grocery drive in Lake Charles, Louisiana, after a double hurricane hit the area. They fed firemen in Irvine, California, after the wildfires, visited a South Los Angeles cafe to help support their weekly free grocery drive, and fed the homeless in Skid Row.

"We not only wanted to touch those in need but also just random strangers that could use a smile that day."

Fast forward to today -- the Souper Jenny Kindness Tour 2.0 launched on April 26.

Levison and Morris made their first stop in Colliersville, Tennessee to meet a very special 10-year-old girl who started her own kindness journey this year. Levison says her name is Deontra and she shows up at her favorite places, like a hospital, fire station, Target, or a local restaurant, with snack bags and drinks and simply thanks people for their service. Levison supplemented her snack bags with quarts of soup.



While in Colliersville, Levison also handed out 50 quarts of Turkey Chili to bus drivers and anyone else they came across.

Levison has her own nonprofit called The Zadie Project dedicated to feeding Atlanta's hungry children, families, and seniors. The name honors her father, Jarvin Levison who is known as Zadie (Yiddish for grandfather).

"He is my inspiration for cooking and my motivation for getting involved in my community. He also gave me my very first soup recipe, My Dad's Turkey Chili. In our 18 year history, it is still our most popular soup."

Their next stop was Nashville, where they scrubbed and filled two community fridges, and showed up at the local Waffle House and other local fast-food restaurants to thank workers with free gift cards.



But Levison and Morris aren't just about giving away free food or money, they also take the time while hiking around and exploring wherever they're staying to just bring a smile to someone's face by complimenting them. "Kindness is easy. Kindness can be free," Levison says.

When the two kindness queens landed in Washington D.C. they treated 50 to 60 vaccine workers to an afternoon of pastries and coffee -- just because.



"People ask how I've funded this and let me tell you the answer -- I'm prepared to figure it out! I may end up using my paycheck to spread the kindness gospel, but humanity has been incredibly generous. People hear what we've been doing and they want to get involved. Sometimes, you don't have the time to do the deed and we can do it for you!"




There were people who have donated to make both of the Kindness Tours possible via a GoFundMe page, in addition to dozens in the Atlanta community and Levison's close family and friends, and a significant donor in Sara Blakely and The Spanx Foundation.

The tour ends May 15, if you're interested in following along you can just use @followingsouperjenny or @Meggillentine via Instagram or Meg Gillentine Morris or Jennifer Levison on Facebook.


Rebekah Sager is an award-winning journalist and author with over a decade of experience as a general assignment reporter and writer. She has contributed to the Washington Post, Hollywood Reporter, Playboy, VICE, and more. Her essay is featured in "Chicken Soup for the Soul: I'm Speaking Now: Black Women Share Their Truth in 101 Stories of Love, Courage, and Hope," available June 2021.

via Sasssy Gran / TikTok

A 95-year-old-grandmother has become a sensation on TikTok, a platform that's most popular among the Gen Z set. Doris, also known as Sassy Gran, has become popular for her incredibly bold and refreshingly honest personality.

She's had a tough life which has given her a special edge that you don't find with most nonagenarians. There's also her elegant couture to show the young kids what real class looks like.

Doris was made famous by her grandson Gio who clearly loves going out to dinner with his grandmother and hearing her stories and advice.

Keep Reading Show less
via Sasssy Gran / TikTok

A 95-year-old-grandmother has become a sensation on TikTok, a platform that's most popular among the Gen Z set. Doris, also known as Sassy Gran, has become popular for her incredibly bold and refreshingly honest personality.

She's had a tough life which has given her a special edge that you don't find with most nonagenarians. There's also her elegant couture to show the young kids what real class looks like.

Doris was made famous by her grandson Gio who clearly loves going out to dinner with his grandmother and hearing her stories and advice.

Keep Reading Show less
True

Each year, an estimated 1.8 million people in the United States are affected by cancer β€” most commonly cancers of the breast, lung, prostate, and blood cancers such as leukemia. While not everyone overcomes the disease, thanks to science, more people are surviving β€” and for longer β€” than ever before in history.

We asked three people whose lives have been impacted by cancer to share their stories – how their lives were changed by the disease, and how they're using that experience to change the future of cancer treatments with the hope that ultimately, in the fight against cancer, science will win. Here's what they had to say.

Celine Ryan, 55, engineer database programmer and mother of five from Detroit, MI

Photo courtesy of Celine Ryan

In September 2013, Celine Ryan woke up from a colonoscopy to some traumatic news. Her gastroenterologist showed her a picture of the cancerous mass they found during the procedure.

Ryan and her husband, Patrick, had scheduled a colonoscopy after discovering some unusual bleeding, so the suspicion she could have cancer was already there. Neither of them, however, were quite prepared for the results to be positive -- or for the treatment to begin so soon. Just two days after learning the news, Ryan had surgery to remove the tumor, part of her bladder, and 17 cancerous lymph nodes. Chemotherapy and radiation soon followed.

Ryan's treatment was rigorous – but in December 2014, she got the devastating news that the cancer, once confined to her colon, had spread to her lungs. Her prognosis, they said, was likely terminal.

But rather than give up hope, Ryan sought support from online research, fellow cancer patients and survivors, and her medical team. When she brought up immunotherapy to her oncologist, he quickly agreed it was the best course of action. Ryan's cancer, like a majority of colon and pancreatic cancers, had been caused by a defect on the gene KRAS, which can result in a very aggressive cancer that is virtually "undruggable." According to the medical literature, the relatively smooth protein structure of the KRAS gene meant that designing inhibitors to bind to surface grooves and treat the cancer has been historically difficult. Through her support systems, Ryan discovered an experimental immunotherapy trial at the National Institutes of Health (NIH) in Bethesda, MD., and called them immediately to see if she was eligible. After months of trying to determine whether she was a suitable candidate for the experimental treatment, Ryan was finally accepted.

The treatment, known as tumor-infiltrating lymphocyte therapy, or TIL, is a testament to how far modern science has evolved. With this therapy, doctors remove a tumor and harvest special immune cells that are found naturally in the tumor. Doctors then grow the cells in a lab over the next several weeks with a protein that promotes rapid TIL growth – and once the cells number into the billions, they are infused back into the patient's body to fight the cancer. On April 1, 2015, Ryan had her tumor removed at the NIH. Two months later, she went inpatient for four weeks to have the team "wash out" her immune system with chemotherapy and infuse the cells – all 148 billion of them – back into her body.

Six weeks after the infusion, Ryan and Patrick went back for a follow-up appointment – and the news they got was stunning: Not only had no new tumors developed, but the six existing tumors in her lungs had shrunk significantly. Less than a year after her cell infusion, in April 2016, the doctors told Ryan news that would have been impossible just a decade earlier: Thanks to the cell infusion, Ryan was now considered NED – no evaluable disease. Her body was cancer-free.

Ryan is still NED today and continuing annual follow-up appointments at the NIH, experiencing things she never dreamed she'd be able to live to see, such as her children's high school and college graduations. She's also donating her blood and cells to the NIH to help them research other potential cancer treatments. "It was an honor to do so," Ryan said of her experience. "I'm just thrilled, and I hope my experience can help a lot more people."

Patrice Lee, PhD, VP of Pharmacology, Toxicology and Exploratory Development at Pfizer

Photo courtesy of Patrice Lee

Patrice Lee got into scientific research in an unconventional way – through the late ocean explorer Jacques Cousteau.

Lee never met Cousteau but her dreams of working with him one day led her to pursue a career in science. Initially, Lee completed an undergraduate degree in marine biology; eventually, her interests changed and she decided to get a dual doctoral degree in physiology and toxicology at Duke University. She now works at Pfizer's R&D site in Boulder, CO (formerly Array BioPharma), leading a group of scientists who determine the safety and efficacy of new oncology drugs.

"Scientists focused on drug discovery and development in the pharmaceutical industry are deeply committed to inventing new therapies to meet unmet needs," Lee says, describing her field of work. "We're driven to achieve new medicines and vaccines as quickly as possible without sacrificing safety."

Among the drugs Lee has helped develop during her career, including cancer therapies, she says around a dozen are currently in development, while nine have received FDA approval β€” an incredible accomplishment as many scientists spend their careers without seeing their drug make it to market. Lee's team is particularly interested in therapies for brain metastases β€” something that Lee says is a largely unmet need in cancer research, and something her team is working on from a variety of angles. "Now that we've had rapid success with mRNA vaccine technology, we hope to explore what the future holds when applying this technology to cancers," Lee says.

But while evaluating potential cancer therapies is a professional passion of Lee's, it's also a mission that's deeply personal. "I'm also a breast cancer survivor," she says. "So I've been on the other side of things and have participated in a clinical trial."

However, seeing how melanoma therapies that she helped develop have affected other real-life cancer patients, she says, has been a highlight of her career. "We had one therapy that was approved for patients with BRAF-mutant metastatic melanoma," Lee recalls. "Our team in Boulder was graced by a visit from a patient that had benefited from these drugs that we developed. It was a very special moment for the entire team."

None of these therapies would be available, Lee says without rigorous science behind it: "Facts come from good science. Facts will drive the development of new drugs, and that's what will help patients."

Chiuying "Cynthia" Kuk (they/them) MS, 34, third-year medical student at Michigan State University College of Human Medicine

Photo courtesy of Cynthia Kuk

Cynthia Kuk was just 10 years old when they had a conversation that would change their life forever.

"My mother, who worked as a translator for the government at the time, had been diagnosed with breast cancer, and after her chemotherapy treatments she would get really sick," Kuk, who uses they/them pronouns, recalls. "When I asked my dad why mom was puking so much, he said it was because of the medicine she was taking that would help her get better."

Kuk's response was immediate: "That's so stupid! Why would a medicine make you feel worse instead of better? When I'm older, I want to create medicine that won't make people sick like that."

Nine years later, Kuk traveled from their native Hong Kong to the United States to do exactly that. Kuk enrolled in a small, liberal arts college for their Bachelor's degree, and then four years later started a PhD program in cancer research. Although Kuk's mother was in remission from her cancer at the time, Kuk's goal was the same as it had been as a 10-year-old watching her suffer through chemotherapy: to design a better cancer treatment, and change the landscape of cancer research forever.

Since then, Kuk's mission has changed slightly.

"My mom's cancer relapsed in 2008, and she ended up passing away about five years after that," Kuk says. "After my mom died, I started having this sense of urgency. Cancer research is such that you work for twenty years, and at the end of it you might have a fancy medication that could help people, but I wanted to help people now." With their mother still at the forefront of their mind, Kuk decided to quit their PhD program and enter medical school.

Now, Kuk plans to pursue a career in emergency medicine – not only because they are drawn to the excitement of the emergency room, but because the ER is a place where the most marginalized people tend to seek care.

"I have a special interest in the LGBTQ+ population, as I identify as queer and nonbinary," says Kuk. "A lot of people in this community and other marginalized communities access care through the ER and also tend to avoid medical care since there is a history of mistreatment and judgement from healthcare workers. How you carry yourself as a doctor, your compassion, that can make a huge difference in someone's care."

In addition to making a difference in the lives of LGBTQ+ patients, Kuk wants to make a difference in the lives of patients with cancer as well, like their mother had.

"We've diagnosed patients in the Emergency Department with cancer before," Kuk says. "I can't make cancer good news but how you deliver bad news and the compassion you show could make a world of difference to that patient and their family."

During their training, Kuk advocates for patients by delivering compassionate and inclusive care, whether they happen to have cancer or not. In addition to emphasizing their patient's pronouns and chosen names, they ask for inclusive social and sexual histories as well as using gender neutral language. In doing this, they hope to make medicine as a whole more accessible for people who have been historically pushed aside.

"I'm just one person, and I can't force everyone to respect you, if you're marginalized," Kuk says. "But I do want to push for a culture where people appreciate others who are different from them."